Reactive oxygen species (ROS), by-products of aerobic respiration, promote genetic instability and contribute to the malignant transformation of cells. Among the genes related to ROS metabolism, Bach1 is a repressor of the oxidative stress response, and a negative regulator of ROS-induced cellular senescence directed by p53 in higher eukaryotes. While ROS are intimately involved in carcinogenesis, it is not clear whether Bach1 is involved in this process. We found that senescent Bach1-deficient mouse embryonic fibroblasts (MEFs) underwent spontaneous immortalization the same as did the wild-type cells. When transduced with constitutively active Ras (H-Ras V12 ), the proliferation and colony formation of these cells in vitro were markedly reduced. When transplanted into athymic nude mice, the growth and vascularization of tumors derived from Bach1-deficient cells were also decreased. Gene expression profiling of the MEFs revealed a new H-Ras V12 signature, which was distinct from the previously reported signatures in epithelial tumors, and was partly dependent on Bach1. The Bach1-deficient cells showed diminished phosphorylation of MEK and ERK1/2 in response to H-Ras V12 , which was consistent with the alterations in the gene expression profile, including phosphatase genes. Finally, Bach1-deficient mice were less susceptible to 4-nitroquinoline-1-oxidide (4-NQO)-induced tongue carcinoma than wild-type mice. Our data provide evidence for a critical role of Bach1 in cell transformation and tumor growth induced by activated H-Ras V12 .
INTRODUCTION
Reactive oxygen species (ROS) are inevitable by-products of aerobic respiration. ROS have conventionally been regarded as having carcinogenic potential and profound associations with tumor promotion. 1 First, ROS are one of the major causes of DNA damage in vivo and increase mutations in DNA. 2 Second, the production of ROS is induced in response to growth factors and oncogene activation, and can modulate critical intracellular signaling molecules by affecting their redox regulation. 3 Third, ROS affect heterotypic cell-cell interactions within tumor tissues and also affect angiogenesis. 4 Therefore, changes in ROS metabolism potentially affect both the prevention and promotion of cancer.
In higher eukaryotes, the transcriptional responses toward oxidative stress are regulated by two major transcription factor families, the NF-kB/Rel family and the AP-1 superfamily, which includes Jun. 5 Bach1 is a heme-regulated transcriptional repressor found in vertebrates and is a member of the AP-1 superfamily. 6 Bach1 forms heterodimers with small Maf oncoproteins (MafK, MafF, MafG), binds to the Maf recognition element, which encompasses an AP-1-binding site, 7 and represses the expression of oxidative stress-responsive genes, including heme oxygenase-1 (Hmox1). 8 These genes are activated by Nrf2, which also belongs to the AP-1 superfamily and forms heterodimers with the small Maf proteins. Atherosclerosis and ischemic reperfusion injury of the heart, both involving ROS-mediated damage, are reduced in Bach1-deficient mice compared with wild-type controls, 9, 10 suggesting that Bach1 determines the ROS levels by fine-tuning the expression of oxidative stress-response genes, including Hmox1.
Intriguingly, Bach1 represses the oxidative stress-induced cellular senescence directed by p53. 11 Senescence, induced by the activation of tumor suppressors, inhibits the development of cancer by arresting the proliferation of damaged or stressed cells that are at risk for malignant transformation. 12, 13 Bach1 inhibits p53-mediated cellular senescence by forming a complex with p53, histone deacetylase 1 and nuclear receptor co-repressor, thereby repressing the transcriptional activity of p53. 11 Although oxidative stress is one of the major causes of the senescence of mouse embryonic fibroblasts (MEFs), 14 oncogenic Ras with activating mutations also induces cellular senescence. 15 Importantly, although ROS are essential for Ras-induced cell transformation, 16 little is known about the involvement of the oxidative stress response in Ras-driven tumorigeneisis. The regulation of ROS metabolism and cellular senescence by Bach1 suggest that it may be relevant to tumorigenesis.
Activating mutations in Ras family proto-oncogenes are very common in human cancer, and modulators of aberrant Ras signaling have an important role in tumorigenesis. 17 Recently, there have been several reports describing that there is a large group of genes/proteins that are not oncogenes, but if targeted, can cause reduced proliferation of transformed cells. 18 These phenomena have been interpreted in such a way that activated oncogenes rely on genes that are themselves not oncogenes, thus leading to the so-called 'non-oncogene addiction'. 19 For instance, the Ras family is dependent on the heat shock response in human cancer cells. 18 In this report, we examined the roles of Bach1 in the proliferation and ROS metabolism of transformed cells. Bach1 deficiency did not prevent the immortalization of MEFs despite their enhanced propensity for cellular senescence. However, Bach1 was nearly indispensable for the transformation of immortalized cells with activated Ras (H-Ras V12 ) in vitro, and enhanced the tumor formation in vivo. Bach1 deficiency reduced ROS levels, and profoundly affected the transcriptional response to H-Ras V12 , including the negative feedback loop of extracellular signal-regulated kinase (ERK). These results suggest that Bach1 is a critical factor for Ras-induced transformation and may represent a target gene of non-oncogene addiction by Ras.
RESULTS

Bach1-deficient MEFs bypass senescence in vitro
Senescent MEFs eventually resume proliferation because of the inactivation of p53 and/or p19 ARF , resulting in their immortalization. 20 To examine whether Bach1 deficiency would affect this process beyond the premature entry into senescence, we compared the kinetics of immortalization using senescent wild-type and Bach1-deficient MEFs. While senescent cells developed typical phenotypes, including flattened morphology and cell cycle arrest, immortalized cells (i-MEFs) regained their typical fibroblastic morphology and proliferation capacity irrespective of the Bach1 genotype (Figure 1a) . Although Bach1-deficient MEFs became senescent earlier than wildtype cells, both of the cell types resumed proliferation with the same rate between 30 and 110 days in culture (Figure 1b) . Immortalization did not affect expression level of Bach1 (Figure 1c) . Although the protein and mRNA levels of p19 ARF were higher in Bach1-deficient than in wild-type cells in primary cultures, there was no correlation between the p19 ARF expression and Bach1 genotype in i-MEFs (Figure 1d , data not shown). The mRNA levels of p53 did not differ significantly between the primary or immortalized wild-type or Bach1-deficient cell cultures (Figure 1e) .
The above results indicated that the senescent phenotype was reversible in wild-type and Bach1-deficient MEFs, and that this process involved, at least partly, the inactivation of p19 ARF . Interestingly, the p19 ARF -negative i-MEFs showed higher saturation densities than those expressing p19 ARF , irrespective of the Bach1 genotype (Figure 1f ), thus suggesting that p19 ARF might regulate the inhibition of proliferation induced by cell-to-cell contact. Because the inactivation of p19 ARF appeared to be a random event in immortalization, we selected only the i-MEF cultures that had lost p19 ARF expression for the further analyses.
Bach1 facilitates H-Ras
V12
-induced proliferation and transformation Unlike primary MEFs, i-MEFs can be transformed by single oncogenes, such as H-Ras V12 . 21 We therefore compared the transformation of wild-type and Bach1-deficient i-MEFs by H-Ras
. When transduced with H-Ras V12 , the Bach1-deficient i-MEFs produced smaller numbers of colonies in mono-layered culture (Figure 2a ). When reconstituted with a Bach1-expressing plasmid, Bach1-deficient i-MEFs formed more colonies (Figure 2a) . Therefore, the observed defect was a direct effect of the ablation of Bach1. Similar results were obtained in experiments using p19 ARF -positive cells (data not shown). The overexpression of Bach1 itself in wild-type i-MEFs did not induce transformation (data not shown), indicating that Bach1 is not a classical oncogene. The proliferation of Bach1-deficient cells expressing H-Ras V12 was slower than that of their wild-type counterparts (Figure 2b ), thus indicating that Bach1 was also required for the vigorous proliferation driven by constitutively active H-Ras
. However, the absence of Bach1 did not affect the expression of H-Ras V12 upon retroviral transduction of immortalized cells, and transformation itself did not change the expression levels of Bach1 (Figure 2c ).
To examine the Bach1 function under more physiologically relevant conditions, we transplanted the H-Ras V12 -transduced cells subcutaneously into the dorsal flanks of athymic nude mice. Tumors derived from wild-type cells were consistently larger compared with their Bach1-deficient counterparts (Figures 3a-c) . Moreover, Bach1-deficient tumors showed notable cellular polymorphism and dyskariosis (Figure 3d ), suggesting that depletion of Bach1 might have induced mitotic stress. Interestingly, the vascularization was more prominent in tumors derived from wild-type cells than from Bach1-deficient cells (Figure 3e (Figure 4a and Table 1 ). Only two genes among those upregulated by Bach1 knockout had Bach1-binding sequences according to the SABiosciences' DECODE database (SABiosciences, Frederick, MD, USA), thus suggesting that their regulation was mostly indirect. Although Bach1 is known to have an important role in the oxidative stress response and heme metabolism, a gene ontology analysis revealed no enrichment of such genes regulating these metabolic processes in i-MEFs. Instead, several genes known to inhibit cell proliferation (Dusp16/MKP-7, Tcf7l1, Esrp2) [22] [23] [24] and angiogenesis (Serpinf1, Tnmd) 25, 26 were expressed in Bach1-deficient cells at higher levels compared with wild-type cells. Among the targets that were suppressed in Bach1-deficient i-MEFs, we identified two genes that might directly affect the signal transduction downstream and upstream of Ras, such as H-Ras palmitoyltransferase (Zdhhc18) and GEF-protein Vav1.
27,28
The expression of oncogenic H-Ras V12 in wild-type i-MEFs resulted in a dramatic change in the gene expression landscape. We identified a group of genes whose expression was induced or suppressed by H-Ras V12 in wild-type but not in Bach1-defifient i-MEFs ( Figure 4b and Table 2 ). Among a total of 96 genes (8 upregulated and 88 downregulated), we observed no clear overlap with the previously published Ras signature obtained from an analysis of epithelial tumors. 29 Interestingly, in contrast to the wild-type i-MEFs, transformation by H-Ras V12 failed to induce the suppression of many genes involved in regulating the transcription, translation and RNA processing in Bach1-deficient cells (Table 2 ). These observations suggested that Bach1 modified the gene expression profile induced by H-Ras V12 .
Bach1 is required to maintain signaling via the ERK signal transduction pathway We found that in Bach1-deficient cells, the transduction of H-Ras V12 resulted in the upregulation of a subset of phosphoprotein phosphatase genes compared with wild-type i-MEFs (Figure 5a ). Only two of these genes (Ptp4a1 and Ppm1b) possess a Maf recognition element, and might be direct transcriptional targets of Bach1. Phosphatases have previously been reported to be an important part of a negative feedback loop impending the activity of the mitogen-activated protein kinase (MAPK) transduction pathway. In particular, Dusp1, Dusp9 and Ppp2cb are potent inhibitors of MAPK activation. [30] [31] [32] [33] [34] The substrate of Cdc14b is Cdc25c, and its overexpression induces cell cycle arrest by activating mitotic check point. 35 By validating the microarray results by qPCR, we confirmed the upregulation of the phosphatase genes, which might contribute to the phenotype of H-Ras-transformed Bach1-defifient i-MEFs in our experimental model ( Figure 5b ). As the Ras-induced proliferation and cellular transformation of murine cell lines are dependent on the activation of the MAPK cascade, 36 we examined the phosphorylation of ERK1/2. The phosphorylation of ERK1/2 was clearly induced by H-Ras V12 in the wild-type i-MEFs, but not in the Bach1-deficient i-MEFs ( Figure 5c ).
We carried out a kinetic analysis of ERK1/2 activation in response to serum stimulation after starvation. The phosphorylation of ERK1/2 was markedly induced between 10 and 30 min after serum stimulation in wild-type cells. In contrast, it was not obvious in Bach1-deficient cells (Figure 6a ). The phosphorylation of MEK, a kinase upstream of ERK, showed similar patterns. In contrast, the phosphorylation of Akt, a downstream effector of Ras, was not induced, and did not differ between wild-type and Bach1-deficient cells (Figure 6a ). Interestingly, we observed no differences in the phosphorylation of ERK1/2 and MEK between wild-type and Bach1-deficient i-MEFs in the absence of H-Ras V12 ( Figure 6b ). The phosphorylation of ERK and MEK was clearly observed in Bach1- Figure 4 . Changes in gene expression in response to oncogenic Ras in Bach1-deficient i-MEFs. (a) Heat map visualizations of the 82 genes that were more than twofold differentially expressed genes in Bach1-deficient i-MEFs compared with WT i-MEFs. The data are normalized and represented as median-centered log-transformed values, using average linkage clustering on entities and conditions. Red and blue correspond to increased and decreased expression, respectively, compared with the experiment-wide median. (b) A heat map of the 96 genes expression of which was changed more than twofold in WT but not in Bach1-deficient i-MEFs after transduction with H-Ras V12 . The data are expression ratios of the normalized gene expression levels with and without H-Ras V12 , and are presented as median-centered log-space data. Clustering and visualization were performed as described above.
Bach1 as a possible target of non-oncogene addiction A Nakanome et al Enhanced feedback regulation of ERK in the absence of Bach1 A strong activation of the Ras-MAPK cascade is known to result in its negative feedback inhibition as a result of the induction of phosphatases. 37 Therefore, the increased expression of phosphatases (Figures 5a and b) may be responsible for the alterations in ERK activation induced in Bach1-deficient cells by H-Ras V12 . To examine this possibility, we treated cells with okadaic acid, an inhibitor of serine-threonine phosphatases (Figure 6c) , and orthovanadate, an inhibitor of tyrosine phosphatases (Figure 6d ). Similar levels of ERK1/2 phosphorylation were observed in both types of cells in the presence of a higher concentration of the inhibitors. These results suggested that the protein kinases upstream of ERK1/2 were functional, and that the reduced ERK1/2 phosphorylation was, at least in part, due to increased phosphatase activity.
To further localize the target of the negative feedback inhibition of the MAPK pathway in Bach1-deficient cells, we expressed a constitutively active Raf mutant fused to the ligand-binding domain of the estrogen receptor (Raf-ER) in i-MEFs. 38 When Raf-ER was activated by treatment with tamoxifen, the phosphorylation of ERK1/2 occurred in wild-type cells. Similar levels of ERK1/2 phosphorylation were observed in Bach1-deficient cells (Figure 6e ). Considering that wild-type Raf is regulated by autophosphorylation, 39 these results suggested that enhanced negative feedback regulation might operate upstream of Raf.
Bach1 facilitates the ROS accumulation induced by H-Ras
V12
Ras-induced transformation can lead to the production of ROS through pathways involving flavoprotein and Rac1. 40 Several reports have shown that ROS are essential for transformation by H-Ras V12 and contribute to various aspects of malignancy, including metastasis and angiogenesis. 41, 42 As Bach1 inhibits the expression of HO-1, the activity of which is critical for ROS elimination, 8 we investigated whether the ROS levels might be affected by the Bach1 deficiency. We found that the ROS levels were much higher in wild-type cells than in Bach1-deficient cells in the presence of H-Ras V12 (Figure 7a ). The ROS levels increased in Bach1-deficient i-MEFs when Bach1 expression was restored by retroviral transduction (Figure 7b) . Reciprocally, the ROS levels in wild-type cells expressing H-Ras V12 decreased upon knockdown of Bach1 (Figure 7c ). Taken together, these results suggested that Bach1 facilitated the process of transformation at least in part by sustaining higher ROS levels.
Carcinogen-induced tumor formation is inhibited in Bach1-deficient mice Chronic exposure of mice to 4-nitroquinoline-1-oxide (4-NQO) causes DNA damage and induces invasive squamous cell carcinoma in the oral cavity and esophagus. 43 The 4-NQOinduced squamous cell carcinoma in rats often exhibits activating mutations in H-Ras. 44 To test the hypothesis that Bach1 as a possible target of non-oncogene addiction A Nakanome et al Bach1 as a possible target of non-oncogene addiction A Nakanome et al
Bach1 could facilitate carcinogen-induced tumor formation in mice, we exposed wild-type and Bach1-deficient mice to 4-NQO in their drinking water. All but two wild-type mice survived the 16-week treatment period and for the 8 weeks post-treatment. There were no differences in the body weight loss between the wildtype and Bach1-deficient survivors (Figure 8a ). Multiple precancerous and cancerous lesions of the tongues and esophagi developed in all mice (N ¼ 36) regardless of their genotype during the 8 weeks following carcinogen treatment (Figure 8b ). The carcinogenic process in the tongues and esophagi was multifocal and polymorphic. We observed papillomas, as well as endophytic tumors invading through the basal membrane (Figure 8c ). The total number of tumors per animal was higher in wild-type than in Bach1-deficient mice (Figure 8d ). The number of the tongue lesions was also significantly higher in wild-type mice. The difference in the numbers of esophageal lesions was nonsignificant ( Figure 8d ). We also observed no difference in the total tumor volume between the mice of different genotypes (Figure 8e ). There were no malignant lesions in the lungs, livers or stomachs, irrespective of the genotype of the mice (N ¼ 6). These . DNA was stained with Hoechst 33258. Magnification, Â 400.
Bach1 as a possible target of non-oncogene addiction A Nakanome et al results suggest that Bach1 was required in vivo for cellular transformation, rather than for tumor growth and progression.
DISCUSSION
In this study, we showed that Bach1 was necessary for effective transformation of mouse fibroblasts by H-Ras V12 in vitro and in vivo, as well as for the squamous cell carcinoma formation induced by 4-NQO in mice. These two alterations caused by the Bach1 deficiency may be related in terms of the underlying molecular mechanisms. The results described here suggest possible interconnected mechanisms regulating cell transformation (Figure 9 ), and are discussed below.
First, the reduced ERK signaling in the absence of Bach1 may cause the two phenotypic changes. It was especially important that Bach1 deficiency blunted the ERK signaling only in the presence of the H-Ras V12 oncogene. The steady state of ERK phosphorylation in the cell is maintained by negative feedback regulation: strong ERK signaling induces a number of protein phosphatases, which abrogate the signaling by removing the activating phosphorylation from Raf, MEK and ERK. 45 In the absence of Bach1, the expression of multiple phosphatases involved in the feedback loop was strongly induced in response to H-Ras V12 . Bach1 may function within the ERK signaling system as a kind of resistor that tunes the engagement of the negative feedback loop (Figure 9 ). When the activity of Bach1 is reduced, the negative feedback loop would then become hyper-inducible in response to H-Ras V12 . The changes in the 4-NQO model in the absence of Bach1 may also reflect altered ERK signaling. As Bach1 itself is regulated by oxidative stress and heme, 7, 8 the present observations suggest a mechanism by which oxidative stress affects ERK signaling and its output, such as cell proliferation. It is not clear at present whether Bach1 directly regulates the phosphatase genes, and further studies are necessary.
The second possibility is that the enhanced expression of antioxidant and detoxification enzymes driven by Nrf2 46 resulted in inefficient transformation of Bach1-deficient i-MEFs and reduced the damage caused by 4-NQO. This possibility is supported by the finding that H-Ras V12 increased the ROS levels in wild-type cells, but not in Bach1-deficient cells. Some of the Nrf2 target genes are repressed by Bach1, which binds to their enhancers in competition with Nrf2. 8, 47, 48 For instance, HO-1 expression is induced in the absence of Bach1, 8 and it reduces the ROS levels. 49 This is the reason why 4-NQO-induced damage may be alleviated by the reduction in ROS. Recently, it was reported that activated Ras increases the ROS levels only when it is overexpressed. Rather, endogenously encoded, activated Ras induces Nrf2 transcription, promoting ROS detoxification and tumorigenesis. 50 Therefore, ROS appear to be maintained within a narrow range during transformation based on the balance between Bach1 and Nrf2. The regulation of many known Nrf2 target genes is less dependent on Bach1 in human keratinocytes. 51 Therefore, the genome-wide identification of the Bach1 and Nrf2 target genes is necessary.
Interestingly, neoangiogenesis was less robust in the tumors derived from H-Ras V12 -transduced Bach1-deficient i-MEFs than in the wild-type tumors. The elevated levels of ROS in the presence of Bach1 may induce tumor angiogenesis, because neoangiogenesis in tumors driven by activated Ras involves ROS as a messenger. 4 It is also possible that Bach1 directly or indirectly affects the expression of angiogenic genes, such as VEGF, or inhibitors of angiogenesis. H-Ras V12 is known to induce ROS production dependent on NADPH oxidases. 29 In the present study, we found that H-Ras V12 increased the ROS levels in wild-type cells, but not in Bach1-deficient cells. As several protein phosphatases, such as LMW-PTP, are regulated by the redox status of critical cysteine residues. 52 it is worth examining whether the activity of LMW-PTP or related enzymes is increased in Bach1-deficient cells owing to the lower ROS levels.
Further consideration of the present results reminds us of the emerging concept that oncogene-directed transformation is often dependent on the cellular signal transduction and stress response pathways. 19 Particular oncogenes may heavily depend on certain proteins for their function (non-oncogene addiction). 19 Our study has implications in the concept of non-oncogene addiction, and may represent a target for exploitation. Although Bach1 appears to be largely nonessential for the normal life of mice under controlled laboratory conditions (manuscript in preparation), our current results indicate that H-Ras V12 appears to confer upon cells an increased dependency on Bach1. Bach1 is therefore a new addition to the vast and unexplored landscape of non-oncogene addiction. Like one of the regulators of the heat shock response, heat shock factor 1 (HSF1), 18 Bach1 has important roles in both stress responses and transformation by H-Ras V12 . The proposal that tumor cells can modify their oxidative stress response via Bach1 may explain the ability of the incipient cancer cells to adapt to the insufficient vascularization, hypoxia, oxidative stress and mitotic stress associated with the development and progression of cancer. Therapeutic targeting of Bach1 may result in the selective elimination of the cancer cells by exploiting its metabolic effects on the adaptation of cells to an inappropriate microenvironment or by reinforcing conventional genotoxic stress-based therapies.
MATERIALS AND METHODS
Animal studies
All experimental protocols using mice were approved by the Institutional Animal Care and Use Committee of Tohoku University. Bach1-deficient mice have been described previously. 8 Heterozygous Bach1 þ / À mice were intercrossed to obtain littermates of the desired genotypes. Athymic nude mice (BALB/cAJc1-nu/nu) were purchased from CLEA Japan (Tokyo, Japan).
Plasmids
The pBabe-puro-H-Ras V12 expression vector was kindly provided by Nobuyuki Tanaka from Nippon Medical University. The pcDNA3.1-Bach1 and pBabe-puro-Bach1 expression vectors were constructed by digesting the pBSA1 plasmid 7 with SalI, and ligation of the resulting fragments into the cloning sites of the pcDNA3.1 and pBabe-puro vectors, respectively. Raf-ER, a constitutively active form of Raf fused to the ligand-binding domain of the estrogen receptor, was kindly provided by Fuyuki Ishikawa at Kyoto University. 38 
Isolation and immortalization of MEFs
MEFs were prepared and maintained at 37 1C in Dulbecco's modified Eagle medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) (JRH Bioscience, Levexa, KS, USA), 0.1 mM nonessential amino acids (Invitrogen), penicillin/streptomycin (10 000 U/ml each, Invitrogen) and 55 mM 2-mercaptoethanol (Wako Pure Chemicals, Osaka, Japan), as previously described. 11 For immortalization, primary MEFs were cultured under normal conditions. When proliferation ceased, the MEFs were maintained without passage until signs of regrowth became apparent. Then the cultures were replated at a density of 3 Â 10 5 cells per 60 mm culture dish every 3 days. 53 Stable immortalized cultures (i-MEFs) were analyzed for their Bach1, p19 ARF and p53 expression status by an immunoblotting analysis. 54 
Cell treatment
To induce MAPK activation, the cells were deprived of serum (0.05% FBS) for 48 h and then treated with 30% FBS for the indicated periods of time. To inhibit the phosphatase activity, the cells were treated with the indicated concentrations of okadaic acid (Calbiochem, Darmstadt, Germany) or orthovanadate (Sigma, St Louis, MO, USA) for 30 min. Raf-ER was activated by 10 nM of 5-hydroxytamoxifen (Sigma) for 12 h.
Colony formation assay
The pBabe-puro-H-Ras V12 vector was transfected into i-MEFs by electroporation (Amaxa, Lonza Bio, Basel, Switzerland). After transfection, 1 Â 10 6 cells were seeded on 100 mm cell culture dishes and selected by puromycin (10 mg/ml) for 24 h. The medium was changed every 3 days. After 3 weeks, the colonies were visualized by Giemsa staining.
In vivo tumor growth assay and histological analysis The pBabe-puro-H-Ras V12 vector was used to integrate mutant Ras into the cell genome utilizing a retroviral system. 55 Suspensions of H-Ras V12 -transduced i-MEFs (1 Â 10 6 cells in 100 ml of serum-free medium) were mixed with 100 ml of 12 mg/ml Matrigel (Becton Dickinson, Franklin Lakes, NJ, USA) and injected subcutaneously into the dorsal flanks of 8-week-old female athymic nude mice. The animals were euthanized 14 days after transplantation. The tumors were then excised and measured externally with a caliper in two dimensions. The tumor volumes were calculated using the equation V ¼ (L Â W 2 ) Â 0.5, where L was the length and W was the width. Tissue sections were stained with hematoxylin and eosin or a polyclonal goat anti-CD31 (PECAM) antibody (Santa Cruz Biotech, Santa Cruz, CA, USA). The signal for CD31 was visualized by an immunoperoxidase method using diaminobentizin as a substrate. The specimens were examined by an experienced pathologist.
ROS measurement
The cells incubated with DCF-DA (5 mg/ml for 30 min, Molecular Probes, Carlsbad, CA, USA) were washed with phosphate-buffered saline and subjected to FACS (FACS Calibur, Beckton Dickinson) using the Cell Quest software program for acquisition and analysis.
Immunoblotting analysis
Whole cell extracts were prepared as described previously. 11 Lysates were resolved on 7.5-15% SDS-PAGE gels and transferred to PVDF membranes (Millipore, Billerica, MA, USA). The antibodies for detection of GAPDH, ). An anti-Bach1 antibody was described previously. 8 Immunoreactive proteins were detected using ECL blotting reagents (GE Healthcare, Little Chalfont, UK).
Gene expression profiling
All equipment and reagents used for the gene expression profiling were purchased from Agilent Technologies (Santa Clara, CA, USA). Total RNAs were prepared from cells using the Total RNA Isolation minikit. RNA samples were amplified using a Low RNA Input Fluorescent Linear Amplification Kit following the manufacturer's protocol, and labeled with cyanine-3 dye. Labeled samples were incubated with Whole Mouse Genome Array (4 Â 44 K, G4122F) slides for 17 h. The slides were scanned, and the gene expression analysis was performed using the Genespring GX software program version 11. The analyses were carried out in biological triplicates using i-MEFs derived from three wild-type and biological duplicates using two Bach1-deficient independent mouse embryos. In addition, a technical replicate using a mixture of RNAs isolated from the two Bach1 À / À cells in a independent experiment was also carried out.
Real-time qPCR PCR was performed using a Light Cycler instrument in the SYBR green format (Roche Diagnostics, Mannheim, Germany). b-Actin was used as an internal control. The primer sequences for b-actin, 56 p53 57 and Bach1 48 were published previously. The primers sequences for other examined genes are summarized in the Table 3 . The qPCR for Dusp9 was performed in the TaqMan format with commercial gene expression kit (Life Technologies, Tokyo, Japan). To compare effects of H-Ras V12 upon gene expression levels, values were corrected for beta actin and then normalized (z-score, in R software using package: genefilter).
Immunofluorescent analysis
Immunostaining was performed exactly as described previously. 58 Briefly, the cells were fixed in 10% neutral formalin solution and permeabilized with 0.1% SDS and 0.5% Triton-X in phosphate-buffered saline. After incubation with an anti-phospho-ERK1/2 antibody (1:1000, CST Japan) for 30 min at 371 C, an anti-rabbit IgG FITC-conjugated secondary antibody was used to detect the phoshpo-ERK1/2 signal. Nuclei were stained with 10 mM Hoechst 33258 (Sigma). The images were acquired using a Leica FW4000 fluorescent microscopy system (Leica Microsystems, Wetzlar, Germany) and were processed by a 2D deconvolution algorithm.
Chemical carcinogenesis
The experiments were carried out under controlled conditions with a 12-h light/dark cycle. The male and female 8-week-old wild-type or Bach1-deficient C57BL/6 J mice were treated with 4-NQO (Sigma) in their drinking water (100 mg/ml) for 16 weeks. The control group received equivalent volume of DMSO only. The mice were euthanized after 8 weeks posttreatment. The specimens of the tongues and esophagi were stained with hematoxylin and eosin. The tumors were counted and measured externally as described above. The lesions were examined and graded by an experienced pathologist. Figure 9 . Dependence of oncogenic Ras-transformed cells on Bach1. Bach1 buffers the excessive activity of p53 target genes and oxidative stress-response genes, such as Hmox1, in normal cells (gray lines), setting a threshold for senescence. In transformed cells, the adaptive function of Bach1 shifts to the suppression of the negative feedback induced by activated oncogenes and to maintain the ROS levels (black lines), facilitating transformation and tumorigenesis. Bach1 as a possible target of non-oncogene addiction A Nakanome et al
